{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:23:58Z","timestamp":1786123438480,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1213\/ane.0b013e31817b5ebb","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T15:18:53Z","timestamp":1236266333000},"page":"445-451","source":"Crossref","is-referenced-by-count":109,"title":["A Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Three Different Doses of Palonosetron Versus Placebo for Preventing Postoperative Nausea and Vomiting"],"prefix":"10.1213","volume":"107","author":[{"given":"Keith A.","family":"Candiotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony L.","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy I.","family":"Melson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Joo Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210902","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/annonc\/mdg417","article-title":"Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron.","volume":"14","author":"Gralla","year":"2003","journal-title":"Ann Oncol"},{"key":"R2-18-20210902","first-page":"35","article-title":"Measuring the maintenance of daily life activities using the functional living index-emesis (FLIE) in patients receiving moderately emetogenic chemotherapy.","volume":"4","author":"Decker","year":"2006","journal-title":"J Support Oncol"},{"key":"R3-18-20210902","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1476-5381.1995.tb13282.x","article-title":"The interaction of RS 25259\u2013197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.","volume":"114","author":"Wong","year":"1995","journal-title":"Br J Pharmacol"},{"key":"R4-18-20210902","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ddr.430280111","article-title":"Pharmacological properties of dolasetron, a potent and selective antagonist at 5-HT3 receptors.","volume":"28","author":"Miller","year":"1993","journal-title":"Drug Dev Res"},{"key":"R5-18-20210902","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00023210-200519030-00004","article-title":"Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting. Are they all the same?.","volume":"19","author":"Gan","year":"2005","journal-title":"CNS Drugs"},{"key":"R6-18-20210902","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0091270004264641","article-title":"Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects.","volume":"44","author":"Stoltz","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"R7-18-20210902","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1213\/ane.0b013e318172fa74","article-title":"Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.","volume":"107","author":"Rojas","year":"2008","journal-title":"Anesth Analg"},{"key":"R8-18-20210902","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/cncr.11817","article-title":"Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist.","volume":"98","author":"Eisenberg","year":"2003","journal-title":"Cancer"},{"key":"R9-18-20210902","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1213\/00000539-199808000-00043","article-title":"The efficacy of RS-25259, a long-acting selective 5-HT3 receptor antagonist, for preventing postoperative nausea and vomiting after hysterectomy procedures.","volume":"87","author":"Tang","year":"1998","journal-title":"Anesth Analg"},{"key":"R10-18-20210902","first-page":"A703","article-title":"Prevention of Postoperative Nausea and Vomiting (PONV): a dose-ranging study involving palonosetron, a potent 5-HT3 receptor antagonist.","volume":"103","author":"White","year":"2005","journal-title":"Anesthesiology"},{"key":"R11-18-20210902","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000227647","article-title":"Quality of life studies in chemotherapy-induced emesis.","volume":"53","author":"Osoba","year":"1996","journal-title":"Oncology"},{"key":"R12-18-20210902","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00000542-200308000-00033","article-title":"Does the routine prophylactic use of antiemetics affect the incidence of postdischarge nausea and vomiting following ambulatory surgery?","volume":"99","author":"Gupta","year":"2003","journal-title":"Anesthesiology"},{"key":"R13-18-20210902","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/00000542-200204000-00030","article-title":"Systemic review and analysis of postdischarge symptoms after outpatient surgery.","volume":"96","author":"Wu","year":"2002","journal-title":"Anesthesiology"},{"key":"R14-18-20210902","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jopan.2006.09.001","article-title":"Evidence-based interventions for post discharge nausea and vomiting: a review of the literature.","volume":"21","author":"Odom-Forren","year":"2006","journal-title":"J Perianesth Nurs"},{"key":"R15-18-20210902","first-page":"391","article-title":"Efficacy of promethazine suppositories dispensed to outpatient surgical patients.","volume":"71","author":"Wright","year":"1998","journal-title":"Yale J Biol Med"},{"key":"R16-18-20210902","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/BF03013905","article-title":"Post discharge nausea and vomiting after ambulatory laparoscopy is not reduced by promethazine prophylaxis.","volume":"46","author":"Parlow","year":"1999","journal-title":"Can J Anaesth"},{"key":"R17-18-20210902","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00000542-200211000-00008","article-title":"Comparative efficacy of acustimulation (ReliefBand\u00ae) versus ondansetron (Zofran\u00ae) in combination with droperidol for preventing nausea and vomiting.","volume":"97","author":"White","year":"2002","journal-title":"Anesthesiology"},{"key":"R18-18-20210902","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/00000539-200205000-00027","article-title":"Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery.","volume":"94","author":"Gan","year":"2002","journal-title":"Anest h Analg"},{"key":"R19-18-20210902","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1213\/ane.0b013e31817abcd3","article-title":"A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period.","volume":"107","author":"Kovac","year":"2008","journal-title":"Anesth Analg"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ane.0b013e31817b5ebb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:28:24Z","timestamp":1786112904000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-200808000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e31817b5ebb","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}